Ectopic g-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster

Current Biology

Volumn 10, Issue 4, 2000, Pages 211-214

  Li, H ^a   Chaney, S ^a   Forte, M ^b   Hirsh, J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; DROSOPHILA MELANOGASTER; INSECTA; MELANOGASTER; VERTEBRATA;

EID: 0034708147     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(00)00340-7     Document Type: Article

References (23)

1. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 18:1993;247-291.
2. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 25:1997;192-216.
3. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol. 54:1998;679-720.
4. Kalivas P.W., Pierce R.C., Cornish J., Sorg B.A. A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol. 12:1998;49-53.
5. Strakowski S.M., Sax K.W., Setters M.J., Keck P.E. Jr. Enhanced, response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry. 40:1996;872-880.
6. McClung C., Hirsh J. Stereotypic behavioral responses to free-base cocaine and the development of behavioral sensitization in Drosophila melanogaster. Curr Biol. 8:1998;109-112.
7. Henry D.J., White F.J. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci. 15:1995;6287-6299.
8. Courtney N.D., Howlett A.C., Westfall T.C. Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein. Neurosci Lett. 122:1991;261-264.
9. Pothos E.N., Przedborski S., Davila V., Schmitz Y., Sulzer D. D2-like dopamine autoreceptor activation reduces quantal size in PC12 cells. J Neurosci. 18:1998;5575-5585.
10. Sweeney S.T., Broadie K., Keane J., Niemann H., O'Kane C.J. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron. 14:1995;341-351.
11. Wang Y.M., Gainetdinov R.R., Fumagalli F., Xu F., Jones S.R., Bock C.B.et al. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron. 19:1997;1285-1296.
12. Cole D.G., Kobierski L.A., Konradi C., Hyman S.E. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc Natl Acad Sci USA. 91:1994;9631-9635.
13. Yellman C., Tao H., He B., Hirsh J. Conserved and sexually dimorphic behavioral responses to biogenic amines in decapitated Drosophila. Proc Nat Acad Sci USA. 94:1997;4131-4136.
14. Kalivas P.W. Neural basis of sensitization to cocaine. Hammer R.P. The Neurobiology of Cocaine: Cellular and Molecular Mechanisms. 1995;81-98 CRC Press, Boca Raton.
15. Tolliver B.K., Ho L.B., Fox L.M., Berger S.P. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine. J Pharmacol Exp Ther. 289:1999;38-47.
16. White F.J., Hu X-T., Henry D.J., Zhang S-F. Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration. Hammer R.P. The Neurobiology of Cocaine: Cellular and Molecular Mechanisms. 1995;81-98 CRC Press, Boca Raton.
17. Andretic R., Chaney S., Hirsh J. Circadian genes are required for cocaine sensitization in Drosophila. Science. 285:1999;1066-1068.
18. Renyi L. Long lasting supersensitivity to 5-HT mediated behaviour following monoamine depletion in the rat brain. Acta Pharmacol Toxicol (Copenh). 59:1986;298-302.
19. Hu X.T., Wachtel S.R., Galloway M.P., White F.J. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. J Neurosci. 10:1990;2318-2329.
20. Goodman A., Gilman A. Monoamine oxidase inhibitors. Gilman A., Rall T., Nies A., Taylor P. The Pharmacological Basis of Therapeutics. 1990;417 McGraw-Hill, New York.
21. Trugman J.L., James C.L. Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-dexyglucose. J Neurosci. 12:1992;2875-2879.
22. Takahashi N., Miner L.L., Sora I., Ujike H., Revay R.S., Kostic V.et al. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA. 94:1997;9938-9943.
23. Bainton R.J., Tsai L.T-Y., Singh C.M., Moore M.S., Neckameyer W.S., Heberlein U. Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila. Curr Biol. 10:2000;187-194.